Midwives', Obstetricians', and Recently Delivered Mothers' Perceptions of Remote Monitoring for Prenatal Care: Retrospective Survey.
gestational hypertensive diseases
hypertension, pregnancy-induced
monitoring, ambulatory
questionnaires
remote monitoring
surveys and questionnaires
Journal
Journal of medical Internet research
ISSN: 1438-8871
Titre abrégé: J Med Internet Res
Pays: Canada
ID NLM: 100959882
Informations de publication
Date de publication:
15 04 2019
15 04 2019
Historique:
received:
26
04
2018
accepted:
31
12
2018
revised:
02
12
2018
entrez:
16
4
2019
pubmed:
16
4
2019
medline:
8
2
2020
Statut:
epublish
Résumé
The Pregnancy Remote Monitoring (PREMOM) study enrolled pregnant women at increased risk of developing hypertensive disorders of pregnancy and investigated the effect of remote monitoring in addition to their prenatal follow-up. The objective of this study was to investigate the perceptions and experiences of remote monitoring among mothers, midwives, and obstetricians who participated in the PREMOM study. We developed specific questionnaires for the mothers, midwives, and obstetricians addressing 5 domains: (1) prior knowledge and experience of remote monitoring, (2) reactions to abnormal values, (3) privacy, (4) quality and patient safety, and (5) financial aspects. We also questioned the health care providers about which issues they considered important when implementing remote monitoring. We used a 5-point Likert scale to provide objective scores. It was possible to add free-text feedback at every question. A total of 91 participants completed the questionnaires. The mothers, midwives, and obstetricians reported positive experiences and perceptions of remote monitoring, although most of them had no or little prior experience with this technology. They supported a further rollout of remote monitoring in Belgium. Nearly three-quarters of the mothers (34/47, 72%) did not report any problems with taking the measurements at the required times. Almost half of the mothers (19/47, 40%) wanted to be contacted within 3 to 12 hours after abnormal measurement values, preferably by telephone. Although most of midwives and obstetricians had no or very little experience with remote monitoring before enrolling in the PREMOM study, they reported, based on their one-year experience, that remote monitoring was an important component in the follow-up of high-risk pregnancies and would recommend it to their colleagues and pregnant patients. ClinicalTrials.gov NCT03246737; https://clinicaltrials.gov/ct2/show/NCT03246737 (Archived by WebCite at http://www.webcitation.org/76KVnHSYY).
Sections du résumé
BACKGROUND
The Pregnancy Remote Monitoring (PREMOM) study enrolled pregnant women at increased risk of developing hypertensive disorders of pregnancy and investigated the effect of remote monitoring in addition to their prenatal follow-up.
OBJECTIVE
The objective of this study was to investigate the perceptions and experiences of remote monitoring among mothers, midwives, and obstetricians who participated in the PREMOM study.
METHODS
We developed specific questionnaires for the mothers, midwives, and obstetricians addressing 5 domains: (1) prior knowledge and experience of remote monitoring, (2) reactions to abnormal values, (3) privacy, (4) quality and patient safety, and (5) financial aspects. We also questioned the health care providers about which issues they considered important when implementing remote monitoring. We used a 5-point Likert scale to provide objective scores. It was possible to add free-text feedback at every question.
RESULTS
A total of 91 participants completed the questionnaires. The mothers, midwives, and obstetricians reported positive experiences and perceptions of remote monitoring, although most of them had no or little prior experience with this technology. They supported a further rollout of remote monitoring in Belgium. Nearly three-quarters of the mothers (34/47, 72%) did not report any problems with taking the measurements at the required times. Almost half of the mothers (19/47, 40%) wanted to be contacted within 3 to 12 hours after abnormal measurement values, preferably by telephone.
CONCLUSIONS
Although most of midwives and obstetricians had no or very little experience with remote monitoring before enrolling in the PREMOM study, they reported, based on their one-year experience, that remote monitoring was an important component in the follow-up of high-risk pregnancies and would recommend it to their colleagues and pregnant patients.
TRIAL REGISTRATION
ClinicalTrials.gov NCT03246737; https://clinicaltrials.gov/ct2/show/NCT03246737 (Archived by WebCite at http://www.webcitation.org/76KVnHSYY).
Identifiants
pubmed: 30985286
pii: v21i4e10887
doi: 10.2196/10887
pmc: PMC6487343
doi:
Banques de données
ClinicalTrials.gov
['NCT03246737']
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e10887Informations de copyright
©Dorien Lanssens, Thijs Vandenberk, Joy Lodewijckx, Tessa Peeters, Valerie Storms, Inge M Thijs, Lars Grieten, Wilfried Gyselaers. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 15.04.2019.
Références
Cochrane Database Syst Rev. 2009 Oct 07;(4):CD007536
pubmed: 19821424
Int J Qual Stud Health Well-being. 2013 Dec 16;8:21524
pubmed: 24345687
Int J Endocrinol. 2010;2010:386941
pubmed: 20628517
Telemed J E Health. 2014 May;20(5):428-38
pubmed: 24731239
Hu Li Za Zhi. 2015 Feb;62(1):10-5
pubmed: 25631179
Bone Joint J. 2016 Nov;98-B(11):1450-1454
pubmed: 27803219
Can J Cardiol. 2014 Jul;30(7):765-73
pubmed: 24726053
Women Health. 2011 May;51(3):220-39
pubmed: 21547859
Diabetes Res Clin Pract. 2010 Feb;87(2):e15-7
pubmed: 20044162
Am J Obstet Gynecol. 1996 Nov;175(5):1281-5
pubmed: 8942501
Eur J Obstet Gynecol Reprod Biol. 2018 Apr;223:72-78
pubmed: 29500948
Mayo Clin Proc. 2010 Feb;85(2):180-95
pubmed: 20118395
Anadolu Kardiyol Derg. 2002 Mar;2(1):55-60
pubmed: 12101796
Int J Med Inform. 2008 Jul;77(7):470-6
pubmed: 17923433
Health Care Women Int. 2008 Sep;29(8):784-806
pubmed: 18726792
Prenat Diagn. 2012 Aug;32(8):789-96
pubmed: 22653694
Am J Obstet Gynecol. 1995 Mar;172(3):1026-34
pubmed: 7892843
Iran Red Crescent Med J. 2015 Mar 20;17(3):e24262
pubmed: 26019905
Pediatrics. 2014 Aug;134(2):e535-46
pubmed: 25049351
Front Psychol. 2016 Aug 23;7:1252
pubmed: 27602010
Hemoglobin. 2015;39(3):162-8
pubmed: 25831427
Manag Care. 2001 Nov;10(11):42-6, 48-9
pubmed: 11761593
BMJ. 2002 Apr 13;324(7342):892-5
pubmed: 11950741
Diabetes Care. 2009 Jan;32 Suppl 1:S62-7
pubmed: 19118289
JMIR Mhealth Uhealth. 2017 Mar 09;5(3):e25
pubmed: 28279948
PLoS One. 2011;6(11):e28129
pubmed: 22140522
Eur J Prev Cardiol. 2016 Oct;23(2 suppl):5-12
pubmed: 27892420
Health Care Women Int. 2013;34(6):522-36
pubmed: 23514572
J Med Internet Res. 2018 Mar 26;20(3):e102
pubmed: 29581094
Midwifery. 2013 Apr;29(4):325-31
pubmed: 23159160
Clin Trials. 2016 Aug;13(4):417-24
pubmed: 26968939
Diabetes Technol Ther. 2007 Jun;9(3):297-306
pubmed: 17561800
J Telemed Telecare. 2009;15(5):238-42
pubmed: 19590029
Patient Educ Couns. 2015 Jun;98(6):788-96
pubmed: 25749024